Interventional Cardiology, 2005 (vol. 4), issue 4

Editors&

8217; foreword

Journal of Interventional and Acute Cardiology into its fifth year

Jan Vojáček

Interv Akut Kardiol. 2005;4(4):191  

Original articles

PERIOPERATIVE MONITORING OF CARDIAC SURGICAL PATIENTS WITH THROMBOELASTOGRAPHY

Roman Hájek, Radek Zezula, Ivo Fluger, Jana Růžičková, Jiří Jarkovský, Danka Neméthová

Interv Akut Kardiol. 2005;4(4)

Thromboelastography (TEG) is now an extensively used method of haemostasis monitoring during cardiac surgery. According to the literature, TEG is beneficial to rational therapy and reduces the use of blood products. Methods: We evaluated 128 patients undergoing elective cardiac surgery using cardiopulmonary bypass (CPB) in a prospective study. Patients were monitored with conventional coagulation tests (before and after CPB) and simultaneously with TEG. The 146 patients of the control group were monitored only with laboratory tests and ACT. We evaluated the pathological TEG tracings obtained before, during and after surgery. During the investigation,...

CATHETER ABLATION OF POSTINFARCTION INCESSANT TACHYCARDIA SUPPORTED BY ELECTROANATOMICAL MAPPING

Markéta Koželuhová, Petr Peichl, Robert Čihák, Jan Bytešník, Josef Kautzner

Interv Akut Kardiol. 2005;4(4):205-209  

Incessant forms of ventricular tachycardia (VT) represent a significant therapeutic problem. Although the patients are often implanted with an implantable cardioverter-defibrillator (ICD), incessant character of arrhythmia commonly leads to multiple discharges and/or VT is not detected for its slow rate. The aim of this study is to present an experience with catheter ablation of these arrhythmias using electroanatomical mapping. Methods: In a cohort of 51 patients who underwent catheter ablation of postinfarction VT with an electroanatomical mapping system, 10 patients (all men, mean age 65±12 years) had incessant tachycardia. All had significant...

Review articles

ANTICOAGULANT THERAPY DURING CORONARY ANGIOPLASTY

Ivo Varvařovský

Interv Akut Kardiol. 2005;4(4):218-222  

Anticoagulant therapy is used for prevention of thrombotic complications during coronary angioplasty (PCI). In the last decade, antiplatelet therapy has widely been studied in large randomized trials, while anticoagulant therapy for PCI has remained unaddressed. Optimal anticoagulant treatment therefore remains a pending question. In this review, the role of unfractionated heparin and novel agents in the setting of coronary angioplasty is summarized.

THROMBOELASTOGRAPHY FOR MONITORING OF HAEMOSTASIS IN CARDIAC SURGERY

Roman Hájek, Radek Zezula, Ivo Fluger, Jana Růžičková

Interv Akut Kardiol. 2005;4(4):224-228  

Thromboelastography (TEG) is extensively used method of haemostasis monitoring during cardiac surgery these days. This article explores mechanisms of haemostasis activation during cardiopulmonary bypass and informs about history and priciples of TEG and its using in cardiac surgery.

PATIENT-PROSTHESIS MISMATCH

Jan Dominik

Interv Akut Kardiol. 2005;4(4):229-232  

Patient-prosthesis mismatch /PPM/ is present when the effective orifice area (EAO) of the implanted valve is too small in relation to body surface area of the patient. Haemodynamically significant PPM is defined as an EOA indexed for body surface area less than 0.85 cm2/m2. PPM results in higher transprosthetic gradient and slower and worse left ventricular mass regression. Early mortality of aortic valve replacement is twice higher in case of haemodynamically significant PPM, and even four times higher in patients with left ventricular dysfunction. A prosthesis with the best-possible EOA and a correct technique of implantation is required in a narrow...

Case reports

CORONARY ANGIOGRAPHY AFTER MYOCARDIAL INFARCTION LED TO DIAGNOSIS OF LEFT ATRIAL MYXOMA.

Bihdan Lukáč, Pavol Chňupa

Interv Akut Kardiol. 2005;4(4):236-241  

Introduction: Myxomas are the most frequent cardiac tumours. The variable clinical picture includes symptoms of obstruction, embolisations and nonspecific constitutional signs. Rarely, the first manifestation may also be acute myocardial infarction, as we describe in this case report. Myxomas can create neovascularisations, visible by coronary angiography. Transesophageal echocardiography (TEE) is the diagnostic procedure of choice. Therapy is surgical. Case report: Coronary angiography after myocardial infarction very rarely arouses suspicion of cardiac myxoma. A 57-year-old female patient after first anterior myocardial infarction was evaluated by...

ACUTE MYOCARDIAL INFARCTION CAUSED BY LEFT ATRIAL MYXOMA. USING OF X-SIZER CATHETER

Jan Škvařil, Roman Ondrejčák, Roman Surovčík, Jana Kočárníková, Pavel Jebavý, Štěpán Černý

Interv Akut Kardiol. 2005;4(4):242-244  

59-year-old woman with negative previous history was referred to cath-lab with anterior acute myocardial infarction 4 hours old. X-sizer catheter was used during percutaneous coronary intervention (PCI) to remove suspected thrombus from LAD. Primary success was not achieved. Large left atrial myxoma was diagnosed on echocardiography performed consequently (TTE). The patient was transferred to the cardiosurgery unit and operated (tumour excision, aortocoronary bypass, mitral and tricuspid valvuloplasty). She has remained stable during follow-up.

BLEEDING AND THROMBOTIC COMPLICATION OF PRIMARY PCI

Ivo Bernat, Aleš Kroužecký, Jiří Klečka, Jiří Ferda, Antonín Fikrle

Interv Akut Kardiol. 2005;4(4):245-247  

At present major bleeding is a complication of PCI in less than 5 % and subacute stent thrombosis in less than 2 % in average. We describe life threatening bleeding after primary PCI followed by subacute stent thrombosis after necessary reduction of antithrombotic treatment. Complex therapy led to successful management of both complications, more than one year follow up has been uncomplicated. The definitive infarct size and functional parameters of the left ventricle were evaluated by ECG-gated SPECT imaging.

SPONGIOUS CARDIOMYOPATHY - A RARE CAUSE OF HEART FAILURE

Iveta Hanišová, Michal Čepelák, Kateřina Linhartová, Jiří Ferda

Interv Akut Kardiol. 2005;4(4):248-249  

The authors present a case report of a 60-year-old woman with left ventricle non-compaction as a cause of acute heart failure.

Comments

Acetylsalicylic acid resistance

Jaroslav Malý

Interv Akut Kardiol. 2005;4(4):192-193  

New approaches in the non-pharmacological treatment of recurrent or hemodynamically unstable ventricular tachyarrhythmias

Alan Bulava

Interv Akut Kardiol. 2005;4(4):199-201  

Thromboelastography

Hynek Říha

Interv Akut Kardiol. 2005;4(4):202  

Aortic stenosis. What are the ways to treat it?

Roman Čerbák

Interv Akut Kardiol. 2005;4(4):203-204  

Information

Pulmonary artery rupture with massive haemoptoetreated with soil embolisation

Jaroslav Dušek, Josef Bis, Antonín Krajina, Miroslav Solař, Josef Šťásek, Jiřina Řezáčová, Jan Vojáček

Interv Akut Kardiol. 2005;4(4):250  

Report about the Meeting of European Heart Rhythm Association on the European Society of Cardiology

Miloš Táborský, Petr Neužil

Interv Akut Kardiol. 2005;4(4):251-252  

Tips and Tricks

TIPS AND TRICKS FOR THE CORONARY FLOW RESERVE MEASUREMENT

Petr Kala

Interv Akut Kardiol. 2005;4(4):233-235  

Coronary flow reserve (CFR) is a safe, relatively easy and the only invasive method for assessment of the haemodynamic status of the whole coronary artery. Due its numerous limitations its use is focused on research (syndrome X, left ventricular improvement after acute myocardial infarction, etc.) and the only way to increase the number of CFR investigations is the simultaneously use of combined wires together with FFR.

PS interventional cardiology report

Interventional Cardiology 2004 in the Czech Republic: report of the Working Group on Interventional Cardiology

Michael Želízko

Interv Akut Kardiol. 2005;4(4):253-254  


Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.